Research Keyword: antiviral

Prognostic model for gastric cancer patients with COVID-19 and network pharmacology study on treatment by lentinan

This study investigated how lentinan, a compound from shiitake mushrooms, might help treat patients who have both gastric cancer and COVID-19. Researchers identified five genes that predict patient outcomes and found that lentinan may work by controlling immune cell activity and reducing inflammation. The study suggests lentinan could be a useful additional treatment for this challenging combination of diseases, though more research is needed.

Read More »

Therapeutic and Nutraceutical Potential of Sargassum Species: A Narrative Review

Sargassum is a type of ocean seaweed that has been used in traditional medicine for centuries and contains compounds that may help fight inflammation, oxidative stress, viruses, and bacteria. Scientists have discovered that different Sargassum species produce nearly 200 different bioactive compounds with potential health benefits ranging from reducing arthritis symptoms to supporting immune function. While Sargassum can accumulate harmful heavy metals like arsenic from seawater, researchers have developed effective cleaning methods to remove these contaminants while preserving the beneficial compounds. This makes Sargassum a promising sustainable source of natural medicines and health supplements.

Read More »

Domestication of a magic therapeutical wine glass fungus (Podoscypha petalodes) from Pakistan

Researchers successfully grew Podoscypha petalodes, a medicinal mushroom known as wine glass fungus, under controlled conditions for the first time. The best growth was achieved using a mixture of sawdust and tea waste at 28°C, which produced high yields in just 10 days. This breakthrough means that this therapeutic fungus, which has antiviral and anti-cancer properties, can now be cultivated year-round commercially instead of relying on rare wild specimens.

Read More »

A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms

Chaga mushrooms are a traditional medicine used for centuries in Eastern Europe and Asia that contains powerful compounds beneficial for health. These mushrooms have been shown to help fight cancer, reduce inflammation, boost immunity, and protect cells from damage through their natural antioxidants. Modern scientific research is confirming what traditional healers have known for centuries about this remarkable fungus, making it an increasingly popular natural supplement for health and wellness.

Read More »

Whole genome sequencing and annotations of Trametes sanguinea ZHSJ

Scientists have completely mapped the genetic code of Trametes sanguinea, a medicinal mushroom used in traditional Chinese medicine. They identified over 10,000 genes and analyzed how this mushroom produces compounds that fight tumors, boost immunity, protect the heart, and fight viruses. This genetic map will help researchers understand how to produce these beneficial compounds and develop new medicines from this mushroom.

Read More »

Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound

This study used computer modeling to investigate whether Chaga mushroom components can bind to and potentially block the coronavirus spike protein that SARS-CoV-2 uses to infect cells. The researchers found that three active compounds in Chaga—beta glycan, betulinic acid, and galactomannan—attached strongly to the virus’s binding sites in ways similar to known antiviral molecules. Beyond blocking viral entry, Chaga also has immune-boosting and anti-inflammatory properties that could help prevent the dangerous cytokine storm associated with severe COVID-19.

Read More »

Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review

Ganoderma, a medicinal fungus used in traditional medicine for over 2000 years, contains many beneficial compounds including triterpenes and polysaccharides. Scientific research has confirmed its effectiveness in treating various conditions including cancer, diabetes, infections, and inflammation. The fungus works by boosting the immune system, reducing oxidative stress, and directly inhibiting disease-causing organisms. Modern cultivation methods have made Ganoderma products widely available as supplements and medicines worldwide.

Read More »

Comment on Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2

This is a scientific critique of a recent study claiming that a plant extract called Bi121 has antiviral properties against SARS-CoV-2. The author raises important concerns about how the plant material was prepared and characterized, noting that the chemical fingerprint appears suspiciously identical to a previously published extract, and that the identification of the active ingredient relies on incomplete evidence. The critique calls for more rigorous scientific methods to verify the original study’s findings.

Read More »

Quest for Anti-SARS-CoV-2 antiviral therapeutics: in-silico and in-vitro analysis of edible mushroom- Cordyceps militaris

Researchers tested an edible mushroom called Cordyceps militaris to see if it could fight SARS-CoV-2, the virus that causes COVID-19. Using computer modeling and laboratory experiments, they found that a compound in the mushroom called cordycepin strongly attached to the virus’s spike protein and reduced viral numbers by about 50% in cell cultures. The study supports traditional uses of this mushroom and suggests it could be helpful in managing COVID-19 as the disease becomes endemic.

Read More »

Glucose-6-Phosphate Dehydrogenase Modulates Shiraia Hypocrellin A Biosynthesis Through ROS/NO Signaling in Response to Bamboo Polysaccharide Elicitation

Researchers discovered that a specific enzyme called glucose-6-phosphate dehydrogenase (G6PDH) controls the production of hypocrellin A, a powerful therapeutic compound found in Shiraia fungi. When bamboo polysaccharides are added to fungal cultures, they trigger G6PDH activity, which then increases the production of signaling molecules that boost hypocrellin A biosynthesis. This finding could lead to better ways to produce this promising cancer-fighting photosensitizer at industrial scales using simple, cost-effective methods.

Read More »
Scroll to Top